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Abstract
Background: The neurochemical status and hyperactivity of mice lacking functional substance P-preferring NK1 receptors
(NK1R-/-) resemble abnormalities in Attention Deficit Hyperactivity Disorder (ADHD). Here we tested whether NK1R-/- mice
express other core features of ADHD (impulsivity and inattentiveness) and, if so, whether they are diminished by d-
amphetamine, as in ADHD. Prompted by evidence that circadian rhythms are disrupted in ADHD, we also compared the
performance of mice that were trained and tested in the morning or afternoon.
Methods and Results: The 5-Choice Serial Reaction-Time Task (5-CSRTT) was used to evaluate the cognitive performance of
NK1R-/- mice and their wildtypes. After training, animals were tested using a long (LITI) and a variable (VITI) inter-trial
interval: these tests were carried out with, and without, d-amphetamine pretreatment (0.3 or 1 mg/kg i.p.). NK1R-/- mice
expressed greater omissions (inattentiveness), perseveration and premature responses (impulsivity) in the 5-CSRTT. In NK1R-/-
mice, perseveration in the LITI was increased by injection-stress but reduced by d-amphetamine. Omissions by NK1R-/- mice
in the VITI were unaffected by d-amphetamine, but premature responses were exacerbated by this psychostimulant.
Omissions in the VITI were higher, overall, in the morning than the afternoon but, in the LITI, premature responses of NK1R-/-
mice were higher in the afternoon than the morning.
Conclusion: In addition to locomotor hyperactivity, NK1R-/- mice express inattentiveness, perseveration and impulsivity in
the 5-CSRTT, thereby matching core criteria for a model of ADHD. Because d-amphetamine reduced perseveration in NK1R-/-
mice, this action does not require functional NK1R. However, the lack of any improvement of omissions and premature
responses in NK1R-/- mice given d-amphetamine suggests that beneficial effects of this psychostimulant in other rodent
models, and ADHD patients, need functional NK1R. Finally, our results reveal experimental variables (stimulus parameters,
stress and time of day) that could influence translational studies.
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Introduction
Attention Deficit Hyperactivity Disorder (ADHD) is a heritable,
developmental disorder that affects between 2–5% of children in
the UK but is prevalent worldwide [1]. Its core diagnostic features
are hyperactivity, inattentiveness and impulsivity. The prominence
and combination of these abnormalities define the diagnostic
subtype, viz: Predominantly Inattentive, Predominantly Hyperac-
tive/Impulsive or Combined Type [2]. Perseveration is also
common in this disorder [3] but is not a diagnostic criterion.
Only three compounds are licensed to treat ADHD in the UK
(d-amphetamine, methylphenidate and atomoxetine) [4] but
guanfacine and the prodrug, lisdexamfetamine, are also available
in the USA [5]. All these compounds augment monoamine
transmission in the brain and periphery. However, their
predictable hemodynamic side-effects, the unease about long-term
use of the psychostimulants, d-amphetamine and methylphenidate
(especially in children), and their lack of efficacy in approximately
20–25% of patients (e.g., [6]), justify the need for a better
understanding of the neurobiological abnormalities underlying
ADHD and development of alternative drug treatments.
Mice lacking functional substance P-preferring, neurokinin-1
(NK1) receptors, through either functional ablation of the
tachykinin-1 receptor (tacr1) gene (‘NK1R-/-’, [7) or receptor
antagonism, display locomotor hyperactivity that is prevented by
d-amphetamine or methylphenidate [8,9,10]. There are also
striking abnormalities in the regulation of noradrenergic [8,9]
dopaminergic [10,11] and serotonergic [12] transmission in the
prefrontal cortex and dorsal striatum of NK1R-/- mice. All these
findings are consistent with evidence for dysfunctional corticos-
triatal brain circuits in ADHD (e.g., [13]). Our proposal that
NK1R-/- mice offer a mouse model of this disorder [11] is
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haplotypes in the human tacr1 gene of patients with ADHD
[10,14].
Here, we investigated whether NK1R-/- mice also display
inattentiveness and impulsivity. We compared their behavior with
that of wildtypes in the 5-Choice Serial Reaction-Time Task (‘5-
CSRTT’), which enables evaluation of several aspects of animals’
cognitive performance and response control [15,16,17]. These
include: premature responses (an index of one type of impulsivity (see:
[18])) and perseveration, as well as % incorrect responses and % omissions
(failure to respond in the task), both of which indicate
inattentiveness.
After training the animals to criterion, they were tested under
conditions that increased attentional demand in two different
ways. The first prolonged the inter-trial interval (7 s: ‘LITI’)
during which animals were required to withhold their motor
response. The second used a randomised, variable inter-trial
interval (2–15 s: ‘VITI’). Both procedures increase measures of
inattentiveness and premature responding (see: [19]), but the latter
prevents the time elapsed since the start of the trial from serving as
a cue that would confound measures of animals’ performance. We
then went on to investigate whether any deficits in cognitive
performance and response control in either of these tests are
ameliorated by d-amphetamine.
Finally, there is a great deal of evidence linking disruption of
circadian rhythms with ADHD. For instance, there are reports of:
a polymorphism in the circadian gene, CLOCK [20]; disruption of
sleep rhythms (e.g., [21]) and fluctuation of inattentiveness with
time of day [22] in ADHD patients. NK1R are prevalent in the rat
intergeniculate leaflet, an area implicated in circadian control, and
in the dorsolateral margin of the suprachiasmatic nucleus [23],
which has an undisputed role in regulation of circadian rhythms.
Furthermore, the NK1R antagonist, aprepitant (used clinically as
an anti-emetic), can cause daytime fatigue and insomnia in
humans, while another NK1R antagonist, GR 205 171, disrupts
circadian rhythms of motor activity in rodents [24]. Prompted by
all this evidence, the experimental design enabled us to investigate
whether the performance of NK1R-/- and wildtype mice in the 5-
CSRTT is influenced by the time of day during which the mice
are trained and tested.
Results
Training
We compared the behavior of the two genotypes in two batches
of mice (Cohort 1 and Cohort 2: see Methods). Because no
differences between the two cohorts emerged, the data were
pooled for evaluation of the main effects of genotype and time of
day.
% Omissions (F(1,39)=8.2, P,0.01) and perseveration (F(1,39)=23.3,
P,0.001) were greater in NK1R-/- mice than wildtypes (Fig. 1A
& 1B). Latency to collect the reward was also slightly greater in the
knockouts (F(1,39)=22.8, P,0.001) (Fig. 1C). Accuracy and latency to
correct response were not affected by genotype (Figs. 1D & 1E).
Paradoxically, the incidence of premature responses across Stages 1–6
was greater in wildtype mice than NK1R-/- mice, overall
(F(1,43)=11.5, P,0.001) (Fig. 1F) and increased transiently in
both genotypes during Stage 3 of training, as has been reported
previously [19].
The number of sessions needed for the mice to match the
baseline criteria for testing depended on genotype. NK1R-/- mice
needed more (c.15%) training sessions than wildtypes, overall
(F(1,43)=4.14, P,0.05), but this depended on time of day to some
extent (see below).
Impaired cognitive performance of NK1R-/- mice tested
with a long inter-trial interval (LITI)
Again, there were no differences in the performance of mice
from Cohort 1 and Cohort 2 and so the data were pooled for
evaluation of the main effects of genotype and time of day. When
tested with the LITI, % omissions (F(1,43)=7.63, P,0.01),
perseveration (F(1,43)=5.41, P,0.05) and latency to collect the reward
(F(1,43)=27.1, P,0.001) were all greater in NK1R-/- mice than
the wildtypes (Fig. 2A–C). Other behavioral measures did not
differ in the two genotypes (data not shown).
Impaired cognitive performance of NK1R-/- mice tested
with a variable inter-trial interval (VITI)
The overall incidence of certain behaviors differed in the two
cohorts when tested in the VITI (Table 1). However, no behavior
was influenced by an interaction between Cohort and either
genotype or time of day and so the data from the two cohorts were
pooled for statistical analysis of the main effects of these two
factors.
% Omissions were higher overall in NK1R-/- mice than
wildtypes (F(1,43)=24.59, P=0.001), as were perseveration
(F(1,43)=4.95; P,0.05) and latency to correct response (F(1,43)=13.0,
P,0.001) (Fig. 3A–C). The % premature responses was also greater in
NK1R-/- mice (F(1,39)=14.9, P,0.001) (Fig. 3D), especially with
the longer ITIs (c.f. wildtypes at 10 s and 15 s (post hoc tests):
P,0.001 and P,0.05, respectively). Accuracy was also impaired in
NK1R-/- mice, albeit to a small extent (3%: F(1,39)=7.96, P,0.01;
Fig. 3E). There was no genotype difference in latency to collect the
reward (Fig. 3F).
Saline injection and d-amphetamine modify behavior in
the 5-CSRTT
In the LITI, perseveration was the only behavioral abnormality
expressed by NK1R-/- mice to be ameliorated by d-amphetamine
(Fig. 4A). Specifically, d-amphetamine restored baseline perfor-
mance by preventing an increase in perseveration in NK1R-/- mice
following an i.p. injection (c.f., d-amphetamine and saline:
F(2,34)=5.5, P,0.05). This pattern of changes differed strikingly
from that in wildtypes in which perseveration was reduced by an i.p.
injection (c.f., saline and NI-2: F(1,22)=9.8, P,0.01, t11=2.6,
P,0.05) and unaffected by d-amphetamine.
Saline injection increased % omissions in wildtypes but did not
affect NK1R-/- mice and so abolished the genotype difference
seen in uninjected subjects (c.f., saline and NI-2: F(1,22)=4.7,
P,0.05; Fig. 4B). d-Amphetamine did not reduce % omissions in
either genotype (Fig. 4B). Latency to collect the reward was increased by
saline injection in NK1R-/- mice but unaffected by d-amphet-
amine whereas, in wildtypes, the opposite occurred: this behavior
was unaffected by saline and increased by the higher dose of d-
amphetamine (Fig. 4C). The latency to correct response was not
affected by saline injection in either genotype but was increased by
the higher dose of d-amphetamine in both (Fig. 4D). Neither saline
nor d-amphetamine had any effect on accuracy or premature responses
(data not shown).
In the VITI, saline injection did not affect any behavioral
measure in either genotype whereas both doses of d-amphetamine
abolished the genotype differences in % omissions (Fig. 5A),
perseveration (Fig. 5B) and latency to collect the reward (Fig. 5C). These
effects were a consequence of drug-induced changes in both
genotypes (a reduction in NK1R-/- mice and an increase in
wildtypes), rather than a selective action in NK1R-/- mice, but
there was no statistically significant interaction between drug
treatment and genotype. The higher dose of d-amphetamine
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P,0.05) (Fig. 5D) and slightly reduced the accuracy of wildtypes
(Fig. 5E). There were no drug effects on latency to correct response
(data not shown).
Circadian influences on behavior
Several aspects of animals’ behavior depended on time of day.
During training, wildtypes and NK1R-/- mice trained in the
morning needed more sessions to stabilize at the baseline criterion
for testing than did wildtypes trained in the afternoon (F(1,43)=5.7,
P,0.05) (Fig. 6A). Moreover, premature responses during Stage 3
were lower in NK1R-/- mice trained in the morning than all other
groups (F(1,43)=16.5, P,0.001) (Fig. 6B).
In the LITI, premature responses were influenced by an interaction
between genotype and time of day (F(1,43)=6.6, P,0.05): their
incidence in the NK1R-/- group that were tested in the morning
was only 36% of that in wildtypes but, in the afternoon, this
behavior increased in NK1R-/- mice and no longer differed in the
two genotypes (Fig. 6C).
% Omissions in the VITI was higher (25%), overall, in the
morning than the afternoon (F(1,43)=5.4, P,0.05) but there was
no interaction with genotype (Fig. 6D).
Discussion
Mice lacking functional NK1 receptors are capable of learning
the 5-CSRTT, as has been reported for their background strain
(C57BL/6x129Sv: [25]). However, NK1R-/- mice needed more
training sessions overall and expressed deficits in their cognitive
performance that resembled those found in ADHD patients [see:
Figure 1. The performance of wildtype and NK1R-/- mice during training in the 5-CSRTT. % Omissions, perseveration and latency to collect
the reward are all greater in NK1R-/- mice than wildtypes, regardless of time of day (A–C). There was no difference in accuracy (D) or latency to correct
response (E), but premature responses (F) were greater in wildtypes, especially during Stage 3 of training. Points show mean 6 s.e.m. * P,0.05,
** P,0.01, *** P,0.001. N=23–24 per group.
doi:10.1371/journal.pone.0017586.g001
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ADHD patients in whom a deficit in executive function, rather
than primary learning disability, explains their impaired perfor-
mance [26].
Omissions
There was a greater incidence of omissions (an index of
inattentiveness) in NK1R-/- mice than their wildtypes in all stages
of this study. This was particularly evident during the early stages of
training. The convergence of the performanceof the two genotypes at
Stage 6, suggests that NK1R-/- mice adapt slowly to step-changes in
stimulus parameters, especially prolongation of the ITI (see Table 2:
Materials and Methods). The resurgence of greater %o m i s s i o n sin
NK1R-/- mice when the inter-trial interval was subsequently
adjusted in the LITI and VITI supports this proposal.
The higher % omissions in NK1R-/- mice, during training, is
unlikely to be due to difficulties with task acquisition because
accuracy and latency to correct response did not differ from wildtypes.
These findings, coupled with the locomotor hyperactivity of
NK1R-/- mice [8,11], also rule out problems with motor function
and visual discrimination. Greater % omissions in NK1R-/- mice
could be explained by a reduction in their motivation to respond,
which would be consistent with their greater latency to collect the
reward. However, there was no genotype difference in latency to
correct response (an alternative index of motivation) during training
or the LITI. Furthermore, the two genotypes did not differ in their
latency to collect the reward in the VITI. All these findings offer
evidence against any influence of genotype on animals’ motivation
to respond in this test. The most likely (and usual) interpretation of
a higher incidence of % omissions is that they reflect ‘inattentive-
ness’, which is a core feature of ADHD.
Inattentiveness has been attributed to abnormal (deficient or
excessive) phasic release of norepinephrine in the prefrontal cortex.
The optimal phasic response depends on background tonic activity
[27]). Norepinephrine transmission has also been linked with
attention in the 5-CSRTT [28], especially when the stimulus/reward
contingency is altered [29]. It follows that the greater tonic release of
norepinephrine in corticostriatal brain regions of NK1R-/- mice
[9,11] could contribute to their inattentiveness.
d-Amphetamine had no appreciable effect on % omissions of
NK1R-/- and even tended to increase it in wildtypes, as in
outbred rats [30]. This exacerbation of inattentiveness is unlikely
to be due to any anorectic effect of d-amphetamine because there
were no consistent changes in latency to correct response or latency to
collect the reward in either the LITI or the VITI and the effects of d-
amphetamine on these measures did not differ in the two
genotypes.
If excessive norepinephrine transmission in NK1R-/- mice
underlies their inattentiveness, then it is not surprising that d-
amphetamine, a potent norepinephrine releasing-agent, did not
diminish their inattentiveness. d-Amphetamine would be expected
to be beneficial only in subjects with a deficit in norepinephrine
transmission in the prefrontal cortex. This proposal is supported
by reports that d-amphetamine reduces the inattentiveness of the
Spontaneously Hypertensive Rat (SHR) [31], which is the
benchmark rodent model of ADHD and has a lower concentration
of extracellular norepinephrine in the prefrontal cortex than their
control strain [32]. Therefore, a lack of a therapeutic response to
d-amphetamine might serve as a marker for patients with
polymorphism(s) in the region of the tacr1 gene. The NK1R-/-
mouse model of ADHD predicts that such patients would benefit
from treatments that would augment, or mimic, neurotransmission
governed by activation of NK1R.
Figure 2. The performance of wildtype and NK1R-/- mice tested
with a long ITI (‘LITI’) in the 5-CSRTT. % Omissions (A),
perseveration score (B) and latency to collect the reward (C) are all
greater in NK1R-/- mice than wildtypes, regardless of time of day, when
tested with a long inter-trial interval (LITI). Bars show mean 6 s.e.m
score for each behavior. N=23–24 per group. * P,0.05, ** P,0.01,
*** P,0.001.
doi:10.1371/journal.pone.0017586.g002
Table 1. Behavior of the two cohorts of untreated mice in the
VITI test.
Wildtype NK1R-/-
% Accuracy Cohort 1 ** 98.060.5 95.161.1
Cohort 2 94.760.9 90.961.6
Perseveration score Cohort 1 * 13.362.8 18.763.8
Cohort 2 4.761.0 20.767.9
% Premature responses Cohort 1 ** 16.062.5 25.263.6
Cohort 2 21.262.7 38.564.9
Animals’ accuracy, perseveration and premature responses in the VITI test
differed in the two cohorts, but there was no interaction between ‘cohort’ and
‘genotype’ or ‘time of day’ for any of these behaviors. N=23–24 per group.
* P,0.05, ** P,0.01 (c.f., Cohorts 1 and 2).
doi:10.1371/journal.pone.0017586.t001
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Perseveration of NK1R-/- mice was consistently greater than that
of wildtypes during training in the LITI and VITI. This behavior
is not a diagnostic feature in ADHD but is a common co-morbid
complication [33,34].
A potentially important caveat is that saline injection increased
perseveration of NK1R-/- in the LITI but reduced that of wildtypes.
This suggests that provocation of perseveration by stress is prevented
by activation of NK1R. When d-amphetamine, rather than saline,
was injected there was a dose-dependent attenuation of perseveration
of NK1R-/- mice. Injection of d-amphetamine did not cause any
further reduction in perseveration in wildtypes, possibly because of a
floor effect. A similar, albeit less clear-cut, pattern of changes in
perseveration emerged in the VITI.
Perseveration is typically linked with a deficit in dopaminergic
transmission in the neuronal circuit linking the ventral tegmental
area (VTA), the prefrontal cortex, nucleus accumbens and
dorsomedial striatum [35,36,37]. The reduced extracellular
dopamine in the prefrontal cortex of NK1R-/- mice [10] is
consistent with this proposal. Stress increases release of dopamine
in corticostriatal regions [38] and so would be predicted to reduce
perseveration in wildtypes, as was found here.
Stress also increases release of substance P [39] and activation of
NK1R is essential for the dopamine response to stress [40]. It
follows that a lack of functional receptors in NK1R-/- mice would
blunt the dopamine response to injection-stress and so prevent
inhibition of perseveration. This leads to the possibility that d-
amphetamine mimics the effects of stress by triggering impulse-
independent release of dopamine in the terminal field [41]).
Suppression of perseveration by stress is consistent with evidence that
behavioral control is most impaired in ADHD patients with a
blunted (cortisol) response to stress [42].
On the basis of these findings, we infer that relief of perseveration
by d-amphetamine does not require functional NK1R.
Premature responses
A higher incidence of premature responses (impulsivity) in NK1R-/-
mice was evident during the VITI. Impulsivity has long been
associated with abnormal serotonergic transmission, which disrupts
functional coupling of corticostriatal regions [43,44]. Premature
Figure 3. The performance of wildtype and NK1R-/- mice tested with a variable ITI (‘VITI’) in the 5-CSRTT. NK1R-/- mice show greater %
omissions (A), perseveration score (B) latency to correct response (C), % premature responses (D) but lower % accuracy (E) than wildtypes and no
difference in latency to collect the reward (F), regardless of time of day, when tested with a variable inter-trial interval (VITI). Bars show mean 6 s.e.m
for each behavioral score. * P,0.05, ** P,0.01, *** P,0.001 for differences between group means. N=23–24 per group.
doi:10.1371/journal.pone.0017586.g003
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in the prefrontal cortex [45] and is induced by activation of
serotonin2A or serotonin2C receptors [46,47]. Although other
monoamines can influence impulsivity [e.g., 45, 48, 49, 50], the
greater serotonin release in the prefrontal cortex of NK1R-/- mice,
compared with the wildtypes [12], is consistent with their impulsivity.
A feature shared by the transition from Stage 2 to Stage 3 of
training (when premature responding was increased in both genotypes)
and the VITI test is that prolongation of the ITI is unpredictable
in both cases (see Table 2). This suggests that animals’ response
control is influenced by their anticipation of the light signal and
perception of the time that has passed since the start of the trial, as
has been found in ADHD patients [51,52,53]. Serotonin has a key
role in interval timing [54]: the greater release of this transmitter in
NK1R-/- mice [12] might aggravate impulsivity by disrupting
their perception of the passage of time.
d-Amphetamine did not diminish premature responses in either the
LITI or the VITI: the higher dose even exacerbated this behavior
in the latter test. Because serotonergic transmission is increased in
NK1R-/- mice at baseline [12], a further increase in serotonin
release following administration of a high dose of d-amphetamine
[41,55] would be expected to exacerbate impulsivity.
There are inconsistent reports on the effects of d-amphetamine
on premature responses when (outbred) rats and mice are studied in
the 5-CSRTT: both a reduction (LITI: [30]; LITI or VITI: [56])
and an increase [57,58,59,60] have been reported. Reasons for
these disparate findings are not known, but d-amphetamine does
have beneficial effects in other measures of impulsivity in rodents
(e.g., ‘delay-discounting’: [61]). This could be because different test
procedures probe different types of impulsivity [18], which will
have different neurobiological substrates.
d-Amphetamine also reduces impulsivity in the SHR model of
ADHD [31]. Although, to the best of our knowledge, the SHR has
not been tested in the 5-CSRTT, it is striking that basal
serotonergic release is not increased in their prefrontal cortex
[62]. Evidence suggests that insufficient, as well as excessive,
serotonin transmission can provoke impulsivity (see: [48]) and so it
is possible that a d-amphetamine-induced increase in serotonin
release improves response control in the SHR but not the
NK1R-/- mouse. Furthermore, the lack of any improvement in
the NK1R-/- mouse suggests that the response to d-amphetamine
normally recruits functional NK1R. If so, relief of impulsivity in
ADHD patients with impaired NK1R function would need a
treatment that either augments activation of these receptors or
mimics the downstream response.
Circadian influences
The incidence of both omissions and premature responses in
NK1R-/- mice depended on time of day. Omissions in the VITI
were slightly lower in the afternoon but the lack of interaction
between genotype and time of day means that NK1R do not
influence this circadian change. Nevertheless, it is interesting that
inattentiveness in ADHD is more pronounced in patients who
orient their behavior towards the evening (‘owls’ or ‘evening
types’: [22]), especially in the Predominantly Inattentive subgroup.
By contrast, genotype did affect a circadian influence on
premature responding because the transient increase during Stage 3 of
training did not occur in NK1R-/- mice trained in the morning. A
Figure 4. Effects of d-amphetamine on the behavior of wildtype and NK1R-/- mice tested with the LITI in the 5-CSRTT. The
perseveration score of NK1R-/- mice is exacerbated by saline injection but ameliorated by d-amphetamine: the latter has no effect in the wildtypes (A).
d-Amphetamine has no effect on % omissions in either genotype (B) but increases latency to reward in wildtypes (C) and latency to correct response (D)
in both genotypes. Bars show mean 6 s.e.m for the behavior of either untreated mice, tested for the second time with the LITI (NI-2), or mice given
an i.p. injection of saline (Sal) or d-amphetamine (0.3 mg/kg, ‘A(0.3)’ or 1 mg/kg, ‘A(1)’). The mice experienced each treatment, once only, at weekly
intervals. The sequence of treatments (including NI-2) was pseudo-randomised (latin-square) across the subjects. The black line linking adjacent bars
indicates a genotype difference, regardless of time of day, of P,0.05, at least. N=12 per group. * P,0.05, ** P,0.01, *** P,0.001 for comparisons of
group means indicated above the bars.
doi:10.1371/journal.pone.0017586.g004
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impulsivity has been found in humans, also [63]. The lack of any
effect of time of day on premature responses in the VITI could suggest
that exacerbation of impulsivity by unpredictable, prolonged ITIs
masks any circadian influences on this behavior.
NK1R are abundantly expressed in the intergeniculate leaflet of
the mouse and, to a lesser extent, by neurons along the dorsolateral
border region of the suprachiasmatic nucleus [64]. Both areas are
strongly linked with circadian rhythms and their entrainment.
Abnormal neurotransmission at either of these sites could disrupt a
circadianregulationofprematureresponses inNK1R-/- mice. Whether
or not thisis correct, ourfindings suggest that time of daymight be a
key variable in studies of ADHD patients and that the effect of an
interaction between NK1R function and circadian rhythms on
response control merits further investigation.
Conclusion
NK1R-/- mice display deficits in cognitive performance and
response control that resemblediagnostic features of ADHD: namely,
inattentiveness, impulsivity and perseveration. Injection stress
increased perseveration in NK1R-/- mice and this increase was
prevented by d-amphetamine, which otherwise did not diminish the
performance deficits in this genotype. The incidence of omissions
(VITI) and premature responses (LITI) were influenced by time of day.
Moreover, the incidence of the latter behavior depended on an
interaction between genotype and time of day, suggesting coupling
between NK1R activation and neuronal circuits that govern
circadian rhythms and response control. Collectively, our findings
consolidate the NK1R-/- mouse asa model of ADHD, possiblyofthe
Predominantly Inattentive subtype and further suggest that time of
day, the test parameters, and stress are variables that could influence
the outcome of translational studies.
Materials and Methods
Ethics Statement
These experiments were licensed under the Animals (Scientific
Procedures) Act, 1986 (UK) and had local ethical approval at
University College London and the University of Sussex.
Figure 5. Effects of d-amphetamine on the behavior of wildtype and NK1R-/- mice tested with the VITI in the 5-CSRTT. d-
Amphetamine did not affect % omissions (A) or perseveration score (B) but increased latency to collect the reward in both genotypes (C) and %
premature responses in NK1R-/- mice (D). d-Amphetamine slightly reduced the % accuracy of wildtypes, only (E). Bars show mean 6 s.e.m for the
behavior of either untreated mice, tested for the second time with the VITI (NI-2), or mice given an i.p. injection of saline (Sal) or d-amphetamine
(0.3 mg/kg, ‘A(0.3)’ or 1 mg/kg, ‘A(1)’). The mice experienced each treatment once only, at weekly intervals. The sequence of treatments (including NI-
2) was pseudo-randomised (Latin-square) across the subjects. The black line linking adjacent bars indicates a genotype difference of P,0.05, at least,
regardless of time of day. N=11-12 per group. * P,0.05, ** P,0.01, *** P,0.001 of comparisons of groups means indicated above the bars.
doi:10.1371/journal.pone.0017586.g005
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We used male wildtype and NK1R-/- mice (25–40 g and 6–8
weeks of age at the start of each experiment) from a colony based
at UCL. Both genotypes derived from a 129/Sv x C57BL/6
genetic background, crossed with an outbred MF1 strain (Harlan
OLAC, Bicester, UK), for one generation, many generations ago
[7]. The facility was held at 2162uC, 4565% humidity, and a
12:12 h light: dark cycle (lighting increased gradually from 07.00–
08.00 h). The cages incorporated environmental enrichment and
were cleaned twice a week (bedding: Litaspen Premiun (Lillico)).
Water was freely available throughout the study, from standard
water bottles with a nozzle that penetrated the cage lid. Access to
food (2018 global Rodent Diet (Harlan)) was adjusted to stabilise
each subject at 90% of free-feeding body weight. The mice were
weighed every morning before training/testing in the 5-CSRTT.
In two separate experiments, using the same training/testing
procedures, four mice (in each experiment) were taken, at random,
from three breeding pairs for each genotype. These groups of four
mice were housed together such that every ‘home cage’ contained
four wildtype or four NK1R-/- mice. Two mice of each genotype
from each cage were trained and tested in the morning while the
remainder were trained and tested in the afternoon. These cage
groups were maintained throughout the experiments. One mouse
from each cohort died before the end of the experiment, leaving
N=11 for the remainder of the experiment.
Apparatus (5-CSRTT)
The apparatus comprised four mouse operant chambers, each
housed within a ventilated sound-attenuating box (Med Associates,
St. Albans, VT, USA). The rear wall of the chamber was curved
and incorporated five equally-spaced apertures. Inside each of
these was a stimulus light, used to illuminate the hole, and an
infrared detector for monitoring nose-pokes by the mouse. A hole
in the front wall provided access to a magazine that delivered a
liquid reward (0.01 mL of 30% condensed milk solution), which
was signalled by illumination of the magazine. Head entries into
the magazine, to collect the reward, were scored following
interception of an infrared photo-cell beam. A house-light, to
illuminate the test chamber, was mounted above the magazine.
The presentation of the light stimuli and recording of the animals’
responses were controlled by a Smart Ctrl Package 8IN/16OUT
with an additional interface by MED-PC for Windows (Med
Associates, St. Albans, VT, USA).
5-Choice Serial Reaction-Time Task
Subjects were consistently brought into the laboratory (Monday
to Friday) at 09.30 h and were trained/tested, as described below,
either between 10.00–12.00 h or 13.00–15.00 h. This enabled us
to study circadian influences on behavior. To eliminate any
influence of ‘cage effect’ on behavior, half the mice in each cage
were trained and tested in the morning: the remainder were
Figure 6. Behaviors of NK1R-/- and wildtype mice in the 5-CSRTT that depend on time of day. (A) the number of sessions needed to train
mice to baseline criteria for testing; (B) % premature responses during stage 3 of training; (C) % premature responses in the LITI test; (D) % omissions in
the VITI test. Bars show mean 6 s.e.m. * P,0.05, ** P,0.01 for comparisons indicated. N=23–24 per group.
doi:10.1371/journal.pone.0017586.g006
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day, the same researchers were responsible for all the procedures
in both the morning and afternoon to ensure that variables such as
handling and auditory/olfactory signals were balanced across all
subjects. After being tested in the LITI and the VITI, the first
cohort of mice was used to study the effects of d-amphetamine on
behavior. Findings from a study of the effects of a different drug
challenge in the 5-CSRTT, using the second cohort, will be the
subject of a separate report.
Habituation. Mice were placed in the 5-CSRTT chamber
for 30 min, once-daily for three consecutive days. All the lights in
the apparatus (house light, the five apertures and food magazine)
remained switched on. To receive the liquid reward, mice were
required to nose-poke into the magazine. The reward was given on
a continuous reinforcement schedule and was available for 10 s
after each nose-poke, after which the dipper was retracted and
refilled. The number of head-entries into the magazine and
number of reinforcers earned was recorded on-line.
After three days of habituation, the mice were trained on a non-
spatial schedule. Now, only the lights in the five apertures were
switched on, but every nose-poke (into any hole) was rewarded by
delivery of milk solution to the magazine. Before progressing to
training in the 5-CSRTT, the mice were required to earn more
than 50 reinforcers, for two consecutive days, over a maximum of
10 sessions.
Training. After the habituation phase, the mice were trained
to carry out the 5-CSRTT. The difficulty of the task increased
progressively from Stages 1 to 6. To graduate from one stage to
the next, each animal’s behavior had to stabilise at specific
performance criteria (Table 2). Training/testing was carried out
once-daily, five days a week.
At the beginning of each session, the house light and the
magazine light (the latter signalling delivery of the reward) were
switched on. The first trial was started by a nose-poke into the
magazine to collect the reward. After an inter-trial interval (ITI) of
fixed duration (determined by the stage of the training: see Table 2),
the stimulus light in one of the five apertures was switched on, again
for a fixed duration (‘Stimulus Duration’, SD). The animal was
required to nose-poke into the illuminated hole within a fixed time
interval after the onset of the stimulus (‘Limited Hold’, LH). The
sequence for illuminating each of the five holes was randomised. A
correct response was rewarded by delivery of milk to the magazine,
which was signalled by the magazine light (as above). The next trial
of the session was initiated by the mouse collecting the reward.
If the animal did not respond correctly (e.g., nose-poking into a
non-illuminated hole), or failed to nose-poke within the allowed time
(omission error), or responded prematurely (i.e., nose-poke into the
holes during the ITI: i.e., before the onset of the stimulus), the house
light was extinguished for 5 s (‘Time Out’, TO). A nose-poke into any
of the five holes during this period restarted the TO. At the end of the
TO, the mouse was allowed to start the next trial with an unrewarded
nose-poke into the illuminated magazine. Each session finished after
30 min or completion of 100 trials, whichever occurred first.
Performance during long ITI (LITI) or variable ITI (VITI)
test: effect of d-amphetamine. After stable performance at
Stage 6 for at least 7 consecutive days (baseline), treatment-naı ¨ve
mice (NI-1) were tested in a session in which the ITI was
prolonged (7 s) but remained constant (long ITI’: ‘LITI’). The
stimulus duration was reduced to 1 s (cf [19]) and the duration of
the session was increased to 45 min. Starting one week later, the
mice were retested, at once-weekly intervals, with the same LITI
test but, during these sessions, they were tested 30 min after an
intraperitoneal (i.p.) injection of saline (10 ml/kg) or d-
amphetamine (0.3 or 1 mg/kg), or no injection of either saline
or drug (‘NI-2’). These doses of d-amphetamine were chosen
because they are reported to influence mouse cognition behavior
at doses equivalent to those used to treat ADHD [65] and are
lower than those that increase locomotor activity [66]. The
second, injection-free challenge (NI-2) was to control for
improvement in animals’ performance, as a consequence of
Table 2. Schedule for stimulus parameters during Stages 1 to 6 (training) and testing in the 5-CSRTT.
Pretraining Habituation to apparatus All apparatus lights switched on
Reward from magazine Reward continuously available from magazine
Stimulus holes illuminated constantly All stimulus holes illuminated: reward offered on nose-poke through any hole
Training Only one (of five) stimulus holes is illuminated in any trial. A nose-poke into this hole triggers reward
Stages Parameters used Progression criteria
SD{ (s) LH{ (s) ITI{ (s)
1 30 30 2 .30 correct trials for 2 consecutive days
2 20 20 2 Unchanged
3 10 10 5 .50 correct trials for 2 consecutive days
4 555 .50 correct,
.75% accuracy,
,25% Omission errors for 2 consecutive days
5 2.5 5 5 Unchanged
6 1.8 5 5 Unchanged
Tests Long ITI (LITI) 157 N / A
Variable ITI (VITI) 1.8 5 2, 5, 10, 15 N/A
Drug testing Mice were tested with no treatment (NI-1) and then retested with neither vehicle nor drug treatment (NI-2), or after injection of either vehicle or
d-amphetamine (0.3 or 1 mg/kg i.p). Mice experienced each test condition once, only. The sequence was semi-randomised (Latin-square) with a
one-week interval between each test.
{SD: stimulus duration, LH: limited hold, ITI: inter-trial interval.
doi:10.1371/journal.pone.0017586.t002
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within the series of once-weekly assessments the effects of saline or
d-amphetamine. Every mouse experienced each test condition,
once only. During the intervening week, animals were subject to
once-daily sessions at Stage 6 to ensure that their behavior was
restored to the stable baseline before the next test. This series of
tests was then repeated, substituting a variable ITI (VITI: see
Table 2) for the LITI. The VITI could be any one of four
alternatives (2, 5, 10 or 15 s), delivered on a random schedule.
In a second cohort of mice (‘Cohort 2’), the procedures were the
same with the exception that uninjected mice (N1-1) were tested
withtheVITIbeforetheLITI,soastocounterbalancethe sequence
experienced by Cohort 1, before going on to test the effects of a
different compound at weekly intervals (not reported here).
Behavioral scoring
The following performance variables in the 5-CSRTT training
and tests were scored and stored online:
N Total number of sessions required to pass the training
phase: the sum of all the sessions completed over Training
Stages 1–6.
N Total number of trials completed in each test session:
total correct responses + total incorrect responses + total
omissions during the LITI or VITI test.
N % Accuracy: [correct responses/(correct + incorrect respons-
es)]6100.
N % Omissions: [total omissions/(correct + incorrect respons-
es + omissions)]6100.
N % Premature responses: [premature responses/(correct +
incorrect + omissions + premature responses)]6100.
N Latency to correct response: latency to nose-poke into the
correct hole after the onset of stimulus.
N Latency to collect the reward (reach the magazine):
latency to collect the reinforcer after a correct response.
N Perseveration score: total number of responses into the
same, correct hole during the interval between a correct
response and collection of the reinforcer.
Statistical analysis
Statistical analyses were carried out on the raw data, log10-
transformed, (score + 1)log10-transformed or square-root-trans-
formed data, according to whichever produced the least significant
value in the Levene’s test. We pooled data from the two cohorts if
the influence of the factor(s) of interest on behavior did not differ, as
in the training sessions and the LITI. In the VITI, there were
differences in the incidence of certain aspects of behavior of the two
cohorts (Table 1). However, there was no interaction between the
factor ‘Cohort’ and either ‘genotype’ or ‘time of day’ (i.e., the
influence of neither ‘genotype’ nor ‘time of day’ depended on
cohort) and so we again pooled the data when looking for main
effects of these two factors on behavior. The results of all the
statistical comparisons, for all parts of this study, are given in
Supporting Information (Tables S1, S2, S3, S4, S5, S6, S7 and S8).
Raw or transformed data were first analyzed using 3-way
repeated measures ANOVA (SPSS PC
+) with ‘cohort’, ‘genotype’
and ‘time of day’ as between-subjects factors, and ‘training stage’
or ‘test treatment’ as within-subjects factors. In tests of repeated
measures, the Greenhouse-Geisser ‘e’ correction was applied
routinely to data sets that showed statistical significance in
Mauchley’s sphericity test. A significant effect of one of the main
factors, or a relevant interaction between them, was used as the
criterion for progressing to 2-way or 1-way ANOVA with post hoc
comparisons of the data (LSD test or matched-pair and/or
independent-samples t-test, or the non-parametric Mann-Whitney
U-test, as appropriate). Statistical significance was set at P,0.05.
Supporting Information
Table S1 Statistical comparisons of behaviour in NK1R-/- and
wildtype mice during training stages 1–6.
(DOC)
Table S2 Number of training sessions needed to match the
baseline criteria for testing.
(DOC)
Table S3 Statistical analysis of the effect of genotype and time of
day on behavior of uninjected mice, tested for the first time (NI-1),
with a long ITI (LITI).
(DOC)
Table S4 Statistical analysis of the effect of genotype and time of
day on behavior of uninjected mice, tested for the first time (NI-1),
with a variable ITI (VITI).
(DOC)
Table S5 Statistical comparisons of behavior during the LITI:
NI-2 versus vehicle-injected mice.
(DOC)
Table S6 Statistical comparisons of behavior in vehicle- and d
amphetamine (0.3 mg/kg or 1 mg/kg (i.p.)) treated mice in the
LITI.
(DOC)
Table S7 Statistical comparisons of behavior during the VITI:
NI-2 versus vehicle-injected mice.
(DOC)
Table S8 Statistical comparisons of behavior in vehicle- and d
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